相关实验视频
Updated: Jun 1, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
使用现实世界的数据对2型糖尿病疾病进展的建模:量化疾病和死亡的竞争风险
Hanna Kunina1, Stefan Franzén2,3, Maria C Kjellsson1
1Department of Pharmacy, Uppsala University, Uppsala, Sweden.
CPT: pharmacometrics & systems pharmacology
|January 18, 2025
概括
这项研究开发了2型糖尿病 (T2D) 并发症的风险预测框架,如宏血管并发症 (MVC) 和糖尿病病 (DKD). 该模型显示,这些条件显著降低了T2D患者的预期寿命.
科学领域:
- 内分泌学和新陈代谢学
- 公共卫生 公共卫生
- 生物统计学 生物统计学
背景情况:
- 2型糖尿病 (T2D) 是一种进展性代谢障碍,与严重的长期并发症和增加的死亡率有关.
- 对诸如大血管并发症 (MVC) 和糖尿病病 (DKD) 等并发症的有效风险评估对于管理T2D患者的死亡率至关重要.
研究的目的:
- 建立对T2D患者MVC和DKD风险的预测框架,将死亡视为竞争风险.
- 量化MVC和DKD对新诊断T2D个体的预期寿命的影响.
主要方法:
- 利用了2005-2013年瑞典国家糖尿病登记处 (NDR) 中41517名T2D患者的现实数据.
- 开发了一个五州多州模型,使用四分之三的数据来分析MVC,DKD,联合发病率和死亡的竞争风险.
- 调查了有关发病风险和死亡率的独立假设.
主要成果:
- 大多数患者没有出现并发症,但随着时间的推移,发展并发症和死亡的可能性会增加.
- 死亡风险受到MVC和DKD存在的显著影响.
- 与无并发性T2D相比,预期寿命减少了5.0年 (MVC),9.7年 (DKD) 和12.2年 (联合发病率).
结论:
- 一个包含竞争风险的五个州多州模型对于评估新诊断的T2D患者的并发症风险是有效的.
- 该框架为T2D的死亡风险管理提供了有价值的见解.
- 对MVC和DKD的早期风险评估对于改善T2D患者的长期结果至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Actuarial Approach
61
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
61
Mechanistic Models: Compartment Models in Individual and Population Analysis
26
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
26
Comparing the Survival Analysis of Two or More Groups
141
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
141
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Introduction To Survival Analysis
176
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
176

